Peer Review History
| Original SubmissionJune 30, 2021 |
|---|
|
PONE-D-21-21388Optimised CO2-containing medium for in vitro culture and transportation of mouse preimplantation embryos without CO2 incubatorPLOS ONE Dear Dr. Wakayama, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 04 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Peter J. Hansen Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: “We thank Drs S Kishigami, and Y Fujimoto, and Miss C Yamaguchi for assistance in preparing this manuscript. This work was partially funded by the Japan Society for the Promotion of Science to M.O. (17K15394), to D.I. (JP20J23364); the Naito Foundation to S.W.; Asada Science Foundation to T.W.; and the Takeda Science Foundation to T.W.” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This work was partially funded by the Japan Society for the Promotion of Science to M.O. (17K15394), to D.I. (JP20J23364); the Naito Foundation to S.W.; Asada Science Foundation to T.W.; and the Takeda Science Foundation to T.W.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: - Wakayama et al. present an interesting series of studies aimed at simplifying the embryo culture process by eliminating the need for a CO2 incubator and facilitating embryo transport without cryopreservaton. Since much of the need for CO2 is due to the use of bicarbonate as the buffering agent in the medium, additional discussion of other buffering agents may be useful for the Discussion. Their sealed tube system may be even easier with a medium buffered with HEPES or MOPS instead of CO2? See Swain et al., 2009, Reproductive BioMedicine Online 18(6):799-810. Minor comments: - Lines 66 and 71: Would "equilibrated" be better than “aerated”? - Line 72-73: I would suggest, “…supplied by chemical reaction via a simple handmade device provided adequate saturation of the medium with CO2.” - Lines 110-111: I would suggest, "…increase the partial pressure of CO2 in the medium.” Or “…the amount of dissolved CO2 in the medium.” - Line 127: Please specify if these cultures were performed in sealed tubes in/on a warming device? - Line 183: I would suggest, “…tube to develop normally.” - Line 184: I would suggest, “Therefore we…” - Line 186-187: I would suggest, “…using OptC medium equilibrated in a sealed tube with CO2 produced by an Anaero pouch.” - Line 236-238: I would suggest, “…used, the period of incubation in a thermal bottle did not affect the development rate to the blastocyst.” - Lines 297-298: Differences between 1- and 2-cell embryos in their sensitivity top culture conditions is fairly well established in mice and relevant references should be included here. - Line 305-307: Why couldn’t this method be adapted for domestic animals? - Line 361-362: Some additional information on how the Anaero pouches produce CO2 would be useful. Is there any other products of the reaction released into the air? - Lines 460-462: Chi-square and t-tests should not be used for more than 2 treatments. Reviewer #2: In this new manuscript, the authors propose a new optimised system to culture and transport mouse embryos without a CO2 incubator. This paper is a major improvement of their previous paper as all the equipment required are commercially available. The rates and quality of blastocysts and then of pups obtained are clearly very convincing. I highly recommend publishing this manuscript. I have only minor comments: - I hope tat in the fial version of the tables the sentences like "Control (CO2 incubator)" and " Untreated medium" will fit in one line to make it more clear, same for number and corresponding %. On the PDF I downloaded from the website, only Table 3 was easy to read. - I would remove the last sentence of the conclusion. If ou are doing SCNT or DNA microinjections I suspect ou would need good microinjectors and CO2 incubators in your lab anyway (at least for cell culture). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Optimised CO2-containing medium for in vitro culture and transportation of mouse preimplantation embryos without CO2 incubator PONE-D-21-21388R1 Dear Dr. Wakayama, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Peter J. Hansen Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-21388R1 Optimised CO2-containing medium for in vitro culture and transportation of mouse preimplantation embryos without CO2 incubator Dear Dr. Wakayama: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Peter J. Hansen Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .